These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18308800)

  • 1. MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.
    Verrico CD; Lynch L; Fahey MA; Fryer AK; Miller GM; Madras BK
    J Psychopharmacol; 2008 Mar; 22(2):187-202. PubMed ID: 18308800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters.
    Pifl C; Nagy G; Berényi S; Kattinger A; Reither H; Antus S
    J Pharmacol Exp Ther; 2005 Jul; 314(1):346-54. PubMed ID: 15831439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
    Yamashita M; Fukushima S; Shen HW; Hall FS; Uhl GR; Numachi Y; Kobayashi H; Sora I
    Neuropsychopharmacology; 2006 Oct; 31(10):2132-9. PubMed ID: 16407898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.
    Del Bello F; Sakloth F; Partilla JS; Baumann MH; Glennon RA
    Bioorg Med Chem; 2015 Sep; 23(17):5574-9. PubMed ID: 26233799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
    Yamauchi Y; Izumi T; Unemura K; Uenishi Y; Nakagawa T; Kaneko S
    Neurosci Lett; 2007 Nov; 428(2-3):72-6. PubMed ID: 17949903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the norepinephrine transporter improves behavioral flexibility in rats and monkeys.
    Seu E; Lang A; Rivera RJ; Jentsch JD
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):505-19. PubMed ID: 18604598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.
    Madras BK; Xie Z; Lin Z; Jassen A; Panas H; Lynch L; Johnson R; Livni E; Spencer TJ; Bonab AA; Miller GM; Fischman AJ
    J Pharmacol Exp Ther; 2006 Nov; 319(2):561-9. PubMed ID: 16885432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines.
    Montgomery T; Buon C; Eibauer S; Guiry PJ; Keenan AK; McBean GJ
    Br J Pharmacol; 2007 Dec; 152(7):1121-30. PubMed ID: 17891159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.
    Simmler LD; Liechti ME
    Handb Exp Pharmacol; 2018; 252():143-164. PubMed ID: 29633178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
    Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
    Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA modifies active avoidance learning and recall in mice.
    Trigo JM; Cabrero-Castel A; Berrendero F; Maldonado R; Robledo P
    Psychopharmacology (Berl); 2008 Apr; 197(3):391-400. PubMed ID: 18185919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
    Halberstadt AL; Brandt SD; Walther D; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
    Hayat S; Williams RJ; Rattray M
    J Psychopharmacol; 2006 Mar; 20(2):257-63. PubMed ID: 16510483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of L-5-hydroxytryptophan.
    Wang X; Baumann MH; Dersch CM; Rothman RB
    Neuroscience; 2007 Aug; 148(1):212-20. PubMed ID: 17629409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
    Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
    Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
    Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
    Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.